{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:37:01Z","timestamp":1768081021336,"version":"3.49.0"},"reference-count":16,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Rheumatoid arthritis (RA) is a progressive and inflammatory autoimmune disease that displays high heterogeneity in etiology, clinical presentation, prognosis, and response to therapy [...]<\/jats:p>","DOI":"10.3390\/ijms26125640","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T07:44:23Z","timestamp":1749714263000},"page":"5640","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Novel Multiplex Diagnostic Algorithm for Developing an Optimal Patient-Tailored Therapy in Rheumatoid Arthritis Based on Molecular Stratification"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0798-6262","authenticated-orcid":false,"given":"Angeliki","family":"Margoni","sequence":"first","affiliation":[{"name":"Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-0476","authenticated-orcid":false,"given":"Alice G.","family":"Vassiliou","sequence":"additional","affiliation":[{"name":"First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National and Kapodistrian University of Athens, 10676 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-4527","authenticated-orcid":false,"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kang, E.H., Ha, Y.J., and Lee, Y.J. (2020). Autoantibody biomarkers in rheumatic diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041382"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wu, F., Gao, J., Kang, J., Wang, X., Niu, Q., Liu, J., and Zhang, L. (2021). B Cells in rheumatoid arthritis: Pathogenic mechanisms and treatment prospects. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.750753"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Saas, P., Toussirot, E., and Bogunia-Kubik, K. (2022). Editorial: Recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.836119"},{"key":"ref_4","first-page":"vi10","article-title":"The new ACR\/EULAR classification criteria for RA: How are the new criteria performing in the clinic?","volume":"51","author":"Bykerk","year":"2012","journal-title":"Rheumatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/ar3383","article-title":"Novel multiplex technology for diagnostic characterization of rheumatoid arthritis","volume":"13","author":"Chandra","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Laborde, C.M., Castro-Santos, P., and D\u00edaz-Pe\u00f1a, R. (2020). Contribution of multiplex immunoassays to rheumatoid arthritis management: From biomarker discovery to personalized medicine. J. Pers. Med., 10.","DOI":"10.3390\/jpm10040202"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ciechomska, M., Roszkowski, L., Burakowski, T., Massalska, M., Felis-Giemza, A., and Roura, A.J. (2023). Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.980247"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Formichi, C., Fignani, D., Nigi, L., Grieco, G.E., Brusco, N., Licata, G., Sabato, C., Ferretti, E., Sebastiani, G., and Dotta, F. (2021). Circulating micrornas signature for predicting response to glp1-ra therapy in type 2 diabetic patients: A pilot study. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179454"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wang, S.S., Lewis, M.J., and Pitzalis, C. (2023). DNA methylation signatures of response to conventional synthetic and biologic disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis. Biomedecines, 11.","DOI":"10.3390\/biomedicines11071987"},{"key":"ref_10","first-page":"134","article-title":"Analysis of enrichment pathway, hub gene, and protein-protein interaction network in rheumatoid arthritis and construction of molecular subtypes in peripheral blood","volume":"30","author":"Yuan","year":"2024","journal-title":"Altern. Ther. Health Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Birkner, B., Rech, J., and Stargardt, T. (2020). Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0226754"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/annrheumdis-2015-207900","article-title":"Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment","volume":"75","author":"Rech","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Julia, A., G\u00f3mez, A., L\u00f3pez-Lasanta, M., Blanco, F., Erra, A., Fernandez-Nebro, A., Mas, A.J., P\u00e9rez-Garc\u00eda, C., Vivar, M.L.G., and S\u00e1nchez-Fern\u00e1ndez, S. (2022). Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis. EBioMedicine, 80.","DOI":"10.1016\/j.ebiom.2022.104053"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/gm444","article-title":"An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype","volume":"5","author":"Whitaker","year":"2013","journal-title":"Genome Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.18632\/aging.205435","article-title":"Identification of CD8+ T cell-related biomarkers and immune infiltration characteristic of rheumatoid arthritis","volume":"16","author":"Wang","year":"2024","journal-title":"Aging"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Duvvuri, B., and Lood, C. (2019). Cell-free DNA as a biomarker in autoimmune rheumatic diseases. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00502"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5640\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:50:50Z","timestamp":1760032250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ijms26125640"],"URL":"https:\/\/doi.org\/10.3390\/ijms26125640","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]}}}